197 related articles for article (PubMed ID: 12056927)
1. Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.
Ellis RJ; Moore DJ; Childers ME; Letendre S; McCutchan JA; Wolfson T; Spector SA; Hsia K; Heaton RK; Grant I
Arch Neurol; 2002 Jun; 59(6):923-8. PubMed ID: 12056927
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group.
Ellis RJ; Hsia K; Spector SA; Nelson JA; Heaton RK; Wallace MR; Abramson I; Atkinson JH; Grant I; McCutchan JA
Ann Neurol; 1997 Nov; 42(5):679-88. PubMed ID: 9392566
[TBL] [Abstract][Full Text] [Related]
3. Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion.
Marcotte TD; Deutsch R; McCutchan JA; Moore DJ; Letendre S; Ellis RJ; Wallace MR; Heaton RK; Grant I;
Arch Neurol; 2003 Oct; 60(10):1406-12. PubMed ID: 14568811
[TBL] [Abstract][Full Text] [Related]
4. The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease.
Letendre SL; Cherner M; Ellis RJ; Marquie-Beck J; Gragg B; Marcotte T; Heaton RK; McCutchan JA; Grant I;
AIDS; 2005 Oct; 19 Suppl 3():S72-8. PubMed ID: 16251831
[TBL] [Abstract][Full Text] [Related]
5. Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders.
Letendre SL; McCutchan JA; Childers ME; Woods SP; Lazzaretto D; Heaton RK; Grant I; Ellis RJ;
Ann Neurol; 2004 Sep; 56(3):416-23. PubMed ID: 15349869
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication.
García F; Niebla G; Romeu J; Vidal C; Plana M; Ortega M; Ruiz L; Gallart T; Clotet B; Miró JM; Pumarola T; Gatell JM
AIDS; 1999 Aug; 13(12):1491-6. PubMed ID: 10465072
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people.
Vitiello B; Goodkin K; Ashtana D; Shapshak P; Atkinson JH; Heseltine PN; Eaton E; Heaton R; Lyman WD
AIDS; 2007 Jul; 21(11):1415-22. PubMed ID: 17589187
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting.
Rawson T; Muir D; Mackie NE; Garvey LJ; Everitt A; Winston A
J Infect; 2012 Sep; 65(3):239-45. PubMed ID: 22522289
[TBL] [Abstract][Full Text] [Related]
9. Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure.
Spudich S; Lollo N; Liegler T; Deeks SG; Price RW
J Infect Dis; 2006 Dec; 194(12):1686-96. PubMed ID: 17109340
[TBL] [Abstract][Full Text] [Related]
10. Distribution of Human Immunodeficiency Virus (HIV) Ribonucleic Acid in Cerebrospinal Fluid and Blood Is Linked to CD4/CD8 Ratio During Acute HIV.
Chan P; Patel P; Hellmuth J; Colby DJ; Kroon E; Sacdalan C; Pinyakorn S; Jagodzinski L; Krebs S; Ananworanich J; Valcour V; Spudich S;
J Infect Dis; 2018 Aug; 218(6):937-945. PubMed ID: 29741638
[TBL] [Abstract][Full Text] [Related]
11. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain.
McArthur JC; McClernon DR; Cronin MF; Nance-Sproson TE; Saah AJ; St Clair M; Lanier ER
Ann Neurol; 1997 Nov; 42(5):689-98. PubMed ID: 9392567
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus-1 RNA levels in cerebrospinal fluid exhibit a set point in clinically stable patients not receiving antiretroviral therapy.
Ellis RJ; Childers ME; Zimmerman JD; Frost SD; Deutsch R; McCutchan JA;
J Infect Dis; 2003 Jun; 187(11):1818-21. PubMed ID: 12751041
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.
Sevigny JJ; Albert SM; McDermott MP; McArthur JC; Sacktor N; Conant K; Schifitto G; Selnes OA; Stern Y; McClernon DR; Palumbo D; Kieburtz K; Riggs G; Cohen B; Epstein LG; Marder K
Neurology; 2004 Dec; 63(11):2084-90. PubMed ID: 15596754
[TBL] [Abstract][Full Text] [Related]
14. Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study.
Hammond ER; Crum RM; Treisman GJ; Mehta SH; Clifford DB; Ellis RJ; Gelman BB; Grant I; Letendre SL; Marra CM; Morgello S; Simpson DM; Mcarthur JC;
J Neurovirol; 2016 Aug; 22(4):479-87. PubMed ID: 26727907
[TBL] [Abstract][Full Text] [Related]
15. Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy.
Marra CM; Maxwell CL; Collier AC; Robertson KR; Imrie A
BMC Infect Dis; 2007 May; 7():37. PubMed ID: 17475004
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden.
Spudich S; Gisslen M; Hagberg L; Lee E; Liegler T; Brew B; Fuchs D; Tambussi G; Cinque P; Hecht FM; Price RW
J Infect Dis; 2011 Sep; 204(5):753-60. PubMed ID: 21844301
[TBL] [Abstract][Full Text] [Related]
17. Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid of infected children.
Pratt RD; Nichols S; McKinney N; Kwok S; Dankner WM; Spector SA
J Infect Dis; 1996 Aug; 174(2):288-93. PubMed ID: 8699057
[TBL] [Abstract][Full Text] [Related]
18. Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection.
Enting RH; Prins JM; Jurriaans S; Brinkman K; Portegies P; Lange JM
Clin Infect Dis; 2001 Apr; 32(7):1095-9. PubMed ID: 11264039
[TBL] [Abstract][Full Text] [Related]
19. Neurosyphilis Increases Human Immunodeficiency Virus (HIV)-associated Central Nervous System Inflammation but Does Not Explain Cognitive Impairment in HIV-infected Individuals With Syphilis.
Ho EL; Maxwell CL; Dunaway SB; Sahi SK; Tantalo LC; Lukehart SA; Marra CM
Clin Infect Dis; 2017 Sep; 65(6):943-948. PubMed ID: 28525592
[TBL] [Abstract][Full Text] [Related]
20. Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performance.
Hightower GK; Letendre SL; Cherner M; Gibson SA; Ellis RJ; Wolfson TJ; Gamst AC; Ignacio CC; Heaton RK; Grant I; Richman DD; Smith DM;
Virology; 2009 Nov; 394(2):243-8. PubMed ID: 19762060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
